Found 7 matching trials
DSM265 Prophylaxis of Plasmodium Falciparum Malaria PHASE1 The study is a single centre, randomised, placebo-controlled, double-blind ...
Show More Location
Fred Hutchinson Cancer Research Center - Prevention Center
Learn More & Join Trial
A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection PHASE1 Part A
-Cohort 1 DSM265 will be administered as a single dose (400 mg). Fo...
Show More Learn More & Join Trial
Malaria: Relative Bioavailability and Food Effect of DSM265 PHASE1 Phase 1 study designed to evaluate the relative bioavailability of a single...
Show More Location
AbbVie Clinical Pharmacology Research Unit (ACPRU)
Learn More & Join Trial
DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria PHASE1 Study to evaluate the efficacy of DSM265 as a causal prophylactic in a stan...
Show More Location
Universitätsklinikum Tübingen, Institut für Tropenmedizin
Learn More & Join Trial
DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax PHASE2 This will be a Proof-of-concept / Phase IIa, open label study to examine th...
Show More Location
Clínica de la Asociación Civil Selva Amazónica
Learn More & Join Trial
Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects PHASE1 This is a single-dose, fasting and non-fasting, open-label, randomized, thr...
Show More Location
AbbVie Clinical Pharmacology Research Unit (ACPRU)
Learn More & Join Trial
A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 PHASE1 This is a single-centre, open-label, dose finding study using induced blood...
Show More Learn More & Join Trial